Table 5 Concomitant use of drugs increasing serum potassium level (angiotensin-converting enzyme inhibitors + angiotensin II receptor blockers + aldosterone antagonists + potassium-sparing diuretics + potassium-containing agents)
No. of drugs | Total population (n = 4514) | CC | sMDRD | ||
|---|---|---|---|---|---|
< 60 ml/min (n = 1734) | ≥ 60 ml/min (n = 2780) | < 60 ml/min/1.73m2 (n = 855) | ≥ 60 ml/min/1.73m2 (n = 3659) | ||
1 drug; n (%) of patients | 1621 (35.91) | 669 (38.58) | 952 (34.24) | 391 (45.73) | 1230 (33.62) |
2 drugs; n (%) of patients | 506 (11.21) | 258 (14.88) | 248 (8.92) | 180 (21.05) | 326 (8.91) |
3 drugs; n (%) of patients | 105 (2.33) | 54 (3.11) | 51 (1.83) | 30 (3.51) | 75 (2.05) |
4 drugs; n (%) of patients | 4 (0.09) | 1 (0.06) | 3 (0.11) | 1 (0.12) | 3 (0.08) |